Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44)
The summary for the Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44): This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that propose to develop and disseminate evidence-based health information technology (health IT) products that have the potential to 1) prevent or reduce the risk of cancer , 2) facilitate patient-provider communication, and/or 3) improve disease outcomes. The SBC must have received a prior Phase I award or may apply for a Fast-Track (Phase I/Phase II) under this FOA. The purpose of this FOA is to facilitate the transition of SBIR-funded projects to the commercialization stage and to achieve broad scale dissemination of the products. This FOA is expected to promote partnerships between SBC's and large businesses or health-related organizations with the capacity to fully commercialize and disseminate the product. Consistent with the goals of the SBIR funding initiatives, Phase II and Fast-Track SBIR applications must submit a Commercialization Plan, which should include details on how large business or health-related organization(s) will partner with the small business applicant for commercialization and dissemination of the proposed product.
| Federal Grant Title: | Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PA-12-196 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.393 |
| CFDA Descriptions: | Cancer Cause and Prevention Research |
| Current Application Deadline: | Jan 07, 2015 |
| Original Application Deadline: | Jan 07, 2015 |
| Posted Date: | Jun 05, 2012 |
| Creation Date: | Jun 05, 2012 |
| Archive Date: | Feb 07, 2015 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- • Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
- • Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinica...
- • Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
- • Advanced Development of Informatics Technologies for Cancer Research and Management (U24 C...
- • Pilot Studies in Pancreatic Cancer
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- More Grants from the National Institutes of Health
- • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...
- • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
- • Immune Tolerance Network (UM1 Clinical Trial Required)
- • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
- • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
